FDA Approve GastroCHECK For Use In USA
Bedfont announce that the GastroCHECK is now available in the US following regulatory approval from the US Food and Drug Administration (FDA).
• Carbohydrate Breakdown Deficiency
• Lactose Intolerance
• Small instestinal Bacterial Overgrowth (SIBO)
• Determination of time passage through gut
• Irritable Bowel Syndrome (IBS)
The GastroCHECK allows health professionals to accurately detect a range of gastrointestinal disorders. An O2 reading is taken to motivate patients into providing an end-tidal sample. If the patient is unable to do this the GastroCH4ECK™ will automatically correct the reading saving the patient from embarrassment and having to carry out another test.
See: http://www.youtube.com/watch?v=eLBL-xdWvLQ&feature=youtu.be
CONTACT
Mrs Claudia Cuison
Bedfont Scientific Ltd
ask@bedfont.com
www.bedfont.com
+44 (0) 1622 851122
Monday 11 March 2013 / file under Technology | Medical | Healthcare